by Mark Chiang

马克·蒋

Share To

分享到

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to women using weight-loss injections, emphasizing the need for effective contraception while undergoing treatment. The advisory specifically pertains to glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of drugs commonly used for weight management and diabetes treatment.

英国药品和健康产品管理局（MHRA）向使用减肥注射剂的女性发出警告，强调在治疗期间需要采取有效避孕措施。该建议特别涉及胰高血糖素样肽-1受体激动剂（GLP-1RAs），这是一类常用于体重管理和糖尿病治疗的药物。

The agency highlighted concerns about patients obtaining these medications through unregulated sources, where critical safety information may not be adequately disclosed..

该机构强调了对患者通过不受监管的渠道获取这些药物的担忧，因为在这些渠道中，关键的安全信息可能没有得到充分披露。

The MHRA’s alert underscores potential risks associated with GLP-1RAs, particularly regarding their use during pregnancy. These medications are not recommended for pregnant women due to possible adverse effects on fetal development. The agency stressed that women of childbearing age using these treatments should ensure they have access to reliable contraceptive methods to prevent unintended pregnancies while on the medication.

MHRA的警告强调了与GLP-1受体激动剂相关的潜在风险，特别是在妊娠期间使用的问题。由于可能对胎儿发育产生不良影响，这些药物不建议用于孕妇。该机构强调，育龄女性在使用这些治疗时应确保采取可靠的避孕措施，以防止在用药期间发生意外怀孕。

Additionally, the MHRA raised concerns about individuals acquiring GLP-1RAs outside regulated channels, which could lead to insufficient awareness of safety precautions and proper usage guidelines..

此外，MHRA 对个人通过非正规渠道获取 GLP-1RA 表示担忧，这可能导致对安全预防措施和正确使用指南的认识不足。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: June 5, 2025

日期：2025年6月5日

Related posts:

相关文章：

Unified Path to Bliss: Diverse Spiritual Practices Linked by Common Cognitive Process

通往幸福的统一路径：由共同认知过程连接的多样化精神实践

$150 Billion in Savings Expected as Patents Expire on Over 200 Drugs in Next Five Years

预计未来五年内，200多种药物的专利将到期，这将带来1500亿美元的节省。

Study Links Long-Term Use of Some Over-the-Counter Pain Relievers to Elevated Blood Pressure

研究发现长期使用某些非处方止痛药与血压升高有关

Generic Drug Developers Prioritize Stability Testing in FTO Analysis for Biopharmaceuticals.

通用药物开发者在生物制药的FTO分析中优先进行稳定性测试。

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

[email protected]

Author

作者

Mark Chiang

马克·江

Related Post

相关文章

News Flash

新闻快讯

Weill Cornell Researchers Develop Krakencoder Algorithm to Link Brain Structure with Neural Activity

威尔康奈尔医学院研究人员开发出Krakencoder算法，将脑结构与神经活动联系起来。

2025-06-05

2025年6月5日